Asthma drug could help climbers breathe easier at high altitudes
NCT ID NCT06040268
Summary
This study is testing whether an asthma medication called Advair HFA can help prevent high-altitude pulmonary edema (HAPE), a dangerous lung condition that can occur when climbing mountains. Researchers will give the drug or a placebo to 60 healthy volunteers and people prone to HAPE, then measure their breathing and exercise capacity in simulated high-altitude conditions. The goal is to see if this common medication could offer protection for people traveling to high elevations.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALTITUDE EDEMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Colorado Anschutz Medical Campus
RECRUITINGAurora, Colorado, 80045, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.